| Application no. and date | 16823372.4 (espacenet) (Federated) (European Patent Register), 20161201 | | Patent/reg. no. and date | DK/EP 3384049, 20230802 | | Publication date | 20181010 | | Priority no. and date | US 201562262589 P, 20151203, US 201662291274 P, 20160204 | | EP pub. no. and date |
EP 3384049 20181010 | | Effective date | | | Applicant/owner | Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road
Tarrytown, NY 10591, US | | Applicant ref. no. | V464487DK00 | | Inventor | PERLEE, Lorah, c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591, US,
HAMON, Sara, c/o Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591, US,
PAULDING, Charles,
Tarrytown, NY 10591, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | C12Q 1/6883 (2018.01) | | Title | Fremgangsmåder til associering af genetiske varianter med et klinisk resultat hos patienter, der lider af aldersrelateret makuladegeneration behandlet med anti-VEGF | | Int. application no. | US2016064403 | | Int. publication no. | WO2017096031 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
